| Discipline | Clinical pharmacology |
|---|---|
| Language | English |
| Edited by | Mary Yianni |
| Publication details | |
| History | 2008-present |
| Publisher | |
| Frequency | Monthly |
| 3.481 (2019) | |
| Standard abbreviations | |
| ISO 4 | Expert Rev. Clin. Pharmacol. |
| Indexing | |
| CODEN | ERCPAG |
| ISSN | 1751-2433 (print) 1751-2441 (web) |
| OCLC no. | 192040039 |
| Links | |
Expert Review of Clinical Pharmacology is a monthly peer-reviewed medical journal covering all aspects of clinical pharmacology published by Taylor & Francis.
The journal is abstracted and indexed in Chemical Abstracts, EMBASE/Excerpta Medica, MEDLINE/Index Medicus/PubMed, and Scopus. Content focuses on all aspects of clinical pharmacology and accepts both original scholarship as well as reviews. The journal has a rigorous peer-review process. The journal publishes most of the time almost instantly upon acceptance with a normal turnaround time of 72 hours. The current commissioning editor is Jermaine Wilcock. [1]
F1000 is an open research publisher for scientists, scholars, and clinical researchers. F1000 offers a different research evaluation service from standard academic journals by offering peer-review after, rather than before, publishing a research article. Initially, F1000 was named after the 1,000 faculty members that performed peer-reviews, but over time F1000 expanded to more than 8,000 members. When F1000 was acquired by Taylor & Francis Group in January 2020, it kept the publishing services. F1000Prime and F1000 Workspace were acquired by different brands.
The American Journal of Bioethics is a monthly peer-reviewed academic journal published by Taylor & Francis, covering all aspects of bioethics. It publishes target articles, open peer commentaries, editorials, book reviews, and case studies and commentaries in clinical care and research ethics. The journal also publishes special issues that address timely ethical challenges. The editor-in-chief is David Magnus, who was also one of the journals founders.
The British Journal of Pharmacology is a biweekly peer-reviewed medical journal covering all aspects of experimental pharmacology. It is published for the British Pharmacological Society by Wiley-Blackwell. It was established in 1946 as the British Journal of Pharmacology and Chemotherapy, and originally published by the British Medical Association. The journal obtained its current title in 1968.
Expert Opinion on Biological Therapy is a monthly peer-reviewed medical journal covering research on all aspects of biological therapy, including gene therapy and gene transfer technologies, therapeutic peptides and proteins, vaccines and antibodies, and cell- and tissue-based therapies. The journal is published by Taylor & Francis and the editor-in-chief is Michael Morse. The journal was established in 2001 and according to the Journal Citation Reports, it has a 2017 impact factor of 3.974. The journal is also indexed in MEDLINE.
Expert Opinion on Therapeutic Targets is a monthly peer-reviewed medical journal publishing review articles and original papers on recently identified novel molecular drug targets across all therapy areas. It was originally established as Emerging Therapeutic Targets in 1997, changing to its current name in 2001.
Expert Opinion on Drug Delivery is a monthly peer-reviewed medical journal publishing review articles covering all aspects of research on drug delivery, from initial concept to potential therapeutic application and final relevance in clinical use. It was established in 2004 and is published by Taylor and Francis Group. The editor-in-chief is Uday Kompella.
Toxin Reviews is a quarterly peer-reviewed medical journal covering research on multidisciplinary research in the area of toxins derived from animals, plants and microorganisms. The aim is to publish reviews that are of broad interest and importance to the toxicology as well as other life science communities. Toxin Reviews aims to encourage scientists to highlight the contribution of toxins as research tools in deciphering molecular and cellular mechanisms, and as prototypes of therapeutic agents. The reviews should emphasize the role of toxins in enhancing our fundamental understanding of life sciences, protein chemistry, structural biology, pharmacology, clinical toxicology and evolution. Moreover, prominence is given to reviews that propose new ideas or approaches and further the knowledge of toxicology. Toxin Reviews delivers up-to-date research on toxins, their characteristics, activities, and mechanisms of action, ranging in scope from new, underutilized substances, through anti-venoms to chemical and biological weapons. It is published by Taylor & Francis Group. The editor-in-chief is R. Manjunatha Kini, National University of Singapore.
Critical Reviews in Clinical Laboratory Sciences is a peer-reviewed medical journal that publishes review articles on all aspects of clinical laboratory sciences on an invitation-only basis. The journal is published by Taylor and Francis and the editor-in-chief is Khosrow Adeli.
The European Journal of Clinical Pharmacology is a peer-reviewed medical journal published by Springer Science+Business Media since 1968. It covers all aspects of clinical pharmacology and drug therapy in humans.
Clinical Cancer Research is a peer-reviewed medical journal on oncology, including the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer, medical and hematological oncology, radiation therapy, pediatric oncology, pathology, surgical oncology, and clinical genetics. The applications of the disciplines of pharmacology, immunology, cell biology, and molecular genetics to intervention in human cancer are also included. One of the main interests of Clinical Cancer Research is on clinical trials that evaluate new treatments together with research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment. Another priority for Clinical Cancer Research is laboratory and animal studies of new drugs as well as molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease. The journal is published by the American Association for Cancer Research.
Annals of Medicine is a peer-reviewed medical journal that publishes research articles as well as reviews on a wide range of medical specialties, with a particular focus on internal medicine. The journal covers advances in the understanding of the pathogenesis of diseases and in how medicine and molecular genetics can be applied in daily clinical practice. The journal is published 8 times per year by Taylor and Francis Group and the editor-in-chief is Timo Partonen.
The Journal of Psychopharmacology is a monthly peer-reviewed scientific journal published by SAGE Publications on behalf of the British Association for Psychopharmacology. It was established in 1987 and is a member of the Committee on Publication Ethics. The editors-in-chief are David Nutt and Pierre Blier. The journal covers all aspects of psychopharmacology.
Diabetic Hypoglycemia is a triannual open access peer-reviewed medical journal published by ESP Bioscience. It publishes review articles on all aspects of hypoglycemia in diabetes including: basic science, molecular genetics, pathophysiology, epidemiology, and clinical aspects of hypoglycemia prevention, diagnosis and management. The journal was established in 2008, with the support of an unrestricted educational grant from Novo Nordisk. It is abstracted and indexed in EMBASE and Scopus.
Brain Injury is a monthly, peer-reviewed, medical journal published by Taylor & Francis. Furthermore, it is the official journal of the International Brain Injury Association (IBIA). As of April 2024, the editor-in-chief is Nathan Zasler.
The Aging Male is a quarterly peer-reviewed medical journal that covers all aspects of male health throughout the aging process. It is the official journal of the International Society for the Study of the Aging Male and is published by Taylor and Francis Group. The journal is edited by Bruno Lunenfeld (Israel) and was established in 1998.
Cognitive Neuroscience is a peer-reviewed academic journal published four times a year by the Taylor & Francis Group. It publishes empirical and theoretical articles on all topics in the field of cognitive neuroscience. These include perception, attention, memory, language, action, decision-making, emotion, and social cognition. It is co-Edited by Jamie Ward of the University of Sussex and Sharon Thompson-Schill of the University of Pennsylvania.
Clinical Therapeutics is a monthly peer-reviewed medical journal that was established in 1977 and is published by Elsevier. The journal covers all aspects of clinical pharmacology and therapeutics.
Expert Review of Gastroenterology & Hepatology is a peer-reviewed medical journal covering all aspects of gastroenterology and hepatology. It was established in 2007 and is published by Informa.
Expert Review of Anti-infective Therapy is a monthly peer-reviewed medical journal publishing review articles and original papers on all aspects of anti-infective therapy. The journal was established in 2003 and is published by Informa.
Expert Review of Anticancer Therapy is a monthly peer-reviewed medical journal covering all clinical aspects of cancer therapy. It was established in 2001 and is published by Taylor & Francis under the academic publishing division of Informa. The current Editor-in-Chief is Gertjan J L Kaspers who is Head of Pediatric Oncology at VU University Medical Center Amsterdam.
  | This article about a pharmacology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |
